The Allcock test is a specialized angiographic assessment technique used in the imaging of cerebral blood vessels. Developed by pioneering neuroradiologist Dr. James Allcock, the test is designed to determine the extent to which blood flow to the posterior regions of the brain can be maintained through alternative vascular pathways. It remains, to this day, an indispensable preoperative evaluation tool in the treatment of large and giant intracranial aneurysms.
Why Is It Necessary?
Some cerebral aneurysms — abnormal bulges in the walls of blood vessels — cannot be surgically clipped due to their structure or location. In such cases, physicians may elect to deliberately occlude the artery feeding the aneurysm, prompting clot formation within the bulge itself. This approach, however, carries considerable risk: when the main artery is closed off, will the brainstem and surrounding tissue continue to receive an adequate blood supply? The Allcock test exists precisely to answer that question before any irreversible intervention is undertaken.
How Is It Performed?
The test is based on the simultaneous injection of contrast dye into the vertebral artery while manual compression is applied to the carotid artery at the level of the neck. This maneuver allows the treating team to visualize, on angiographic imaging, whether collateral blood flow from the anterior to the posterior circulation is present and sufficient to sustain the brain in the event of arterial occlusion. The procedure is carried out in a specialized neuroradiology unit by an experienced multidisciplinary team.
What Is Its Clinical Significance?
The angiographic appearance of the posterior communicating artery — its patency, diameter, and configuration — serves as one of the most reliable indicators of whether a patient can safely tolerate occlusion of the parent vessel. If adequate collateral flow cannot be demonstrated, the surgical strategy must be reconsidered entirely before proceeding. This makes the Allcock test not merely a diagnostic adjunct, but an intervention that can directly determine the course of treatment and, ultimately, patient survival.
Who Was Dr. Allcock?
Dr. John Allcock was the architect of one of the most productive collaborations in the history of neurosurgery. His partnership with Canadian neurosurgeon Dr. Charles Drake reshaped the standards of complex aneurysm management during an era of rapid surgical innovation. While Drake achieved broad international recognition, Allcock’s contributions long remained in relative obscurity. That his eponymous test has been misspelled as “Alcock” in a number of published articles is, in many ways, a reflection of that undeserved anonymity — one that ongoing efforts in the neurosurgical literature have sought to correct.